PMC:7299399 / 90498-91482
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T367 | 464-468 | Body_part | denotes | skin | http://purl.org/sig/ont/fma/fma7163 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T76 | 464-468 | Body_part | denotes | skin | http://purl.obolibrary.org/obo/UBERON_0000014 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T235 | 835-843 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T759 | 150-155 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T760 | 283-287 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
| T761 | 377-378 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T762 | 464-468 | http://purl.obolibrary.org/obo/UBERON_0000014 | denotes | skin |
| T763 | 464-468 | http://purl.obolibrary.org/obo/UBERON_0001003 | denotes | skin |
| T764 | 464-468 | http://purl.obolibrary.org/obo/UBERON_0002097 | denotes | skin |
| T765 | 464-468 | http://purl.obolibrary.org/obo/UBERON_0002199 | denotes | skin |
| T766 | 464-468 | http://www.ebi.ac.uk/efo/EFO_0000962 | denotes | skin |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T444 | 419-427 | Chemical | denotes | graphene | http://purl.obolibrary.org/obo/CHEBI_36973 |
| T445 | 432-440 | Chemical | denotes | graphene | http://purl.obolibrary.org/obo/CHEBI_36973 |
| T446 | 795-801 | Chemical | denotes | carbon | http://purl.obolibrary.org/obo/CHEBI_27594|http://purl.obolibrary.org/obo/CHEBI_33415 |
| T448 | 871-880 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T373 | 0-163 | Sentence | denotes | Laura Fusco received her B.Sc. in Medical Biotechnologies from the University of Milan (Italy) studying the effects of airborne particulate matter on human health. |
| T374 | 164-608 | Sentence | denotes | After receiving her M.Sc. in Medical Biotechnologies and Molecular Medicine from the University of Trieste (Italy), in 2018, she earned her Ph.D. in Chemistry from the same university (Prof. Maurizio Prato), with a project on the toxicological effects of graphene and graphene-based materials at the skin level, supported by the European Union H2020 Programme, integrating her research at the Karolinska Institutet (Prof. Bengt Fadeel), Sweden. |
| T375 | 609-736 | Sentence | denotes | Currently, she is Visiting Scientist at Sidra Medicine (Qatar) in the framework of the CARBOIMMAP H2020-MSCA-RISE project (L.G. |
| T376 | 737-816 | Sentence | denotes | Delogu coordinator) concerning the immune interactions of carbon nanomaterials. |
| T377 | 817-984 | Sentence | denotes | In the context of COVID-19, she studies the potential antiviral properties of various nanomaterials as well as the role of airborne particulate matter on the outbreak. |